We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$87.2M
AUM Growth
+$25.8M
Cap. Flow
+$18.4M
Cap. Flow %
21.14%
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$883K
2
LHX icon
L3Harris
LHX
+$877K
3
JNJ icon
Johnson & Johnson
JNJ
+$836K
4
INTC icon
Intel
INTC
+$803K
5
PRU icon
Prudential Financial
PRU
+$759K

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$563K
2
COST icon
Costco
COST
+$557K
3
CTAS icon
Cintas
CTAS
+$506K
4
TMO icon
Thermo Fisher Scientific
TMO
+$503K
5
ALK icon
Alaska Air
ALK
+$476K

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Financials 17.3%
3 Industrials 15.25%
4 Healthcare 15.11%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POR icon
376
Portland General Electric
POR
$5.69B
$26K 0.03%
+613
New +$28.1K
ADPT icon
377
Adaptive Biotechnologies
ADPT
$4.04B
$25K 0.03%
509
-1,628
-76% -$59.4K
ETN icon
378
Eaton
ETN
$178B
$25K 0.03%
+291
New +$24K
AMN icon
379
AMN Healthcare
AMN
$1.28B
$24K 0.03%
527
+136
+35% +$6.5K
EL icon
380
Estee Lauder
EL
$31.8B
$24K 0.03%
+128
New +$22.9K
HPP
381
Hudson Pacific Properties
HPP
$724M
$24K 0.03%
+138
New +$23.5K
NKTR icon
382
Nektar Therapeutics
NKTR
$2.55B
$24K 0.03%
68
-89
-57% -$27.8K
ZEN
383
DELISTED
ZENDESK INC
ZEN
$24K 0.03%
276
-1,884
-87% -$145K
PE
384
DELISTED
PARSLEY ENERGY INC
PE
$24K 0.03%
+2,244
New +$20.8K
CARR icon
385
Carrier Global
CARR
$52.4B
$23K 0.03%
+1,050
New +$19.5K
KIM icon
386
Kimco Realty
KIM
$16.1B
$23K 0.03%
1,770
-21,996
-93% -$245K
GRA
387
DELISTED
W.R. Grace & Co.
GRA
$23K 0.03%
+454
New +$21.5K
BFAM icon
388
Bright Horizons
BFAM
$3.76B
$22K 0.03%
188
-773
-80% -$88.2K
NSA
389
DELISTED
National Storage Affiliates Trust
NSA
$22K 0.03%
+772
New +$22.1K
NVAX icon
390
Novavax
NVAX
$1.31B
$22K 0.03%
+266
New +$10.2K
NWL icon
391
Newell Brands
NWL
$2.62B
$22K 0.03%
1,401
+1,131
+419% +$15.5K
AVA icon
392
Avista
AVA
$3.22B
$20K 0.02%
+560
New +$22.2K
RNG icon
393
RingCentral
RNG
$5.3B
$19K 0.02%
67
-199
-75% -$50.3K
TDC icon
394
Teradata
TDC
$2.5B
$19K 0.02%
+911
New +$19.8K
WELL icon
395
Welltower
WELL
$163B
$18K 0.02%
+355
New +$17.4K
FCX icon
396
Freeport-McMoran
FCX
$96.4B
$17K 0.02%
+1,489
New +$13.6K
IPG
397
DELISTED
Interpublic Group of Companies
IPG
$17K 0.02%
+974
New +$16.1K
CTXS
398
DELISTED
Citrix Systems Inc
CTXS
$17K 0.02%
+115
New +$16.5K
BRX icon
399
Brixmor Property Group
BRX
$9.09B
$16K 0.02%
1,255
-23,759
-95% -$268K
ALV icon
400
Autoliv
ALV
$8.96B
$15K 0.02%
+229
New +$13.8K

Similar funds

Neo Ivy Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.

  • Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
  • Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
  • Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
  • Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
  • Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
  • Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
  • Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.